Bandingkan Harga & Kinerja Dayamitra Telekomunikasi Tbk. (MTEL) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Dayamitra Telekomunikasi Tbk. dan Organon Pharma Indonesia Tbk.: Dayamitra Telekomunikasi Tbk. diperdagangkan di Rp478 (kapitalisasi pasar 41,28 T, volume 24 jam 42,08 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Dayamitra Telekomunikasi Tbk. jauh lebih besar — sekitar 395,4× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MTEL | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 41,28 T | 104,4 M |
Volume | 42,08 jt | — |
Lot | 420,83 rb | — |
Perputaran | 20,18 M | — |
Harga Rata-rata | 479,6 | — |
Nilai Transaksi | 20,18 M | — |
Harga Ekuilibrium Indikatif | 478 | — |
Volume Ekuilibrium Indikatif | 102,89 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Dayamitra Telekomunikasi Tbk.
PT Dayamitra Telekomunikasi Tbk. (the Company), previously known as PT Dayamitra Malindo, was established on October 18, 1995 in the framework of the Republic of Indonesia Foreign Investment Law No. 1 of 1967, as amended by Law No. 11 of 1970, with the approval of the President of the Republic of Indonesia in Decree No.B-576/ Pres/10/1995 dated October 16, 1995. The Company changed its name from PT Dayamitra Malindo to PT Dayamitra Telekomunikasi Tbk. by Notarial Deed from Hendra Karyadi, S.H., No. 53 dated August 28, 1997. Furthermore, based on the Decree of theHead of the Investment Coordinating Board No. 244/T/Perhubungan/2006 dated March 22, 2006, the change of the Company's status as foreign investment has changed to domestic.
Selengkapnya di halaman MTEL →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
